1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Clinical Research Proposals is a grant from The ResMed Foundation that funds available for community support. Currently the Foundation plans to disburse a total of up to $1,350,000 annually. The Fo.
The primary focuses of Foundation Grants are "sleep and breathing," with limited funds available for community support. The Foundation will entertain proposals for multi-year studies, if warranted. Eligible applicants include Researchers and institutions conducting studies in sleep and breathing health.
Awards up to Varies.
Get alerted about grants like this
Save a search for “The ResMed Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The ResMed Foundation | Clinical Research Proposals: Guidelines Apply For Funding: Clinical Research Proposals ›› Clinical Research Proposals Application Process & Checklist Grant Application Cover Sheet Proposal Narrative Guidelines ›› Physician and Public Awareness Proposals ›› Community Philanthropy Proposals ›› Douglas/Schwartz Annual Emerging Investigators Research Award ›› Proposal Evaluation Criteria ›› Clinical Research Proposals Application Process & Checklist Grant Application Cover Sheet Proposal Narrative Guidelines ›› Physician and Public Awareness Proposals ›› Community Philanthropy Proposals ›› Douglas/Schwartz Annual Emerging Investigators Research Award ›› Proposal Evaluation Criteria The Foundation's Board of Trustees has determined that funding will fall into the following categories: clinical research, physician and public awareness of the hazards of sleep-disordered breathing, and community philanthropic involvement.
The primary focuses of Foundation Grants are "sleep and breathing," with limited funds available for community support. Currently the Foundation plans to disburse a total of up to $1,350,000 annually. The Foundation will entertain proposals for multi-year studies, if warranted.
However, for multi-year studies the Foundation will require an annual review at which time the board will ascertain whether the funded entity is keeping to its timeline and making progressive steps toward completion. The board may reserve the right to discontinue further funding if a study is not moving forward as outlined in the proposal, nor reaching recruitment goals.
Clinical Research Proposals The ResMed Foundation's key Mission is to promote novel research as well as public and clinician awareness of sleep disordered breathing (SDB) and other respiratory disorders, with a primary focus on positive airway pressure and ventilation-based treatments. The Foundation will consider proposals focused on the evaluation, diagnosis, treatment and management of SDB and other respiratory disorders.
Research areas of interest include the most common and/or impactful comorbidities that are associated with SDB, especially metabolic syndrome including insulin sensitivity, obesity and especially cardiovascular diseases. Other areas of focus include sleep and breathing in conjunction with insomnia, occupational health and safety, asthma, and chronic obstructive pulmonary disease (COPD).
Specific focus is on outcomes which can be rapidly translated into clinical practice. Currently, the ResMed Foundation is particularly interested in: Insomnia: novel diagnostic, phenotypic and treatment pathways with an emphasis on normalizing sleep and breathing. Diagnostic monitoring which more accurately reflects SDB severity.
Novel applications for Positive Airway Pressure. Research proposals that utilize advanced analytics and data science, especially the use of Machine Learning (ML) and Artificial Intelligence (AI), in the analysis of large sets of data from a variety of relevant sources (EHR, lab, claims, sensors/wearables, connected devices, remote physiologic and remote therapeutic monitoring, software/digital health platforms, etc.).
Health Economics and Outcomes Research. Pragmatic research and clinical trials that accelerate the integration of research, policy and practice. Remote management of chronic disease.
Vision of sleep lab/sleep management of the future. The Foundation encourages the publication of results in peer reviewed scientific and medical publications. A few examples of programs that the Foundation has funded are highlighted under Grant Recipients .
Donor recipients must be a qualified tax-exempt organization under section 501 (c) 3 of the US Internal Revenue Service or have the equivalent designation by the federal governing agency in another country. Grants will be given to organizations that demonstrate that they have competent management who have a history of delivering results in an effective and cost efficient manner.
Indirect costs: The Foundation's policy is to consider a maximum of 4% of indirect/overhead costs; however the board's preference is to fund direct (program) costs only. Grants will be awarded with a clear expectation of measurable results and outcomes. Reports to the Foundation will be required minimally on a semi-annual basis.
In some cases quarterly reports are required. At the conclusion of the study a final report is required detailing how the funds were spent and definitive outcomes. The Foundation will be provided a copy of all abstracts and published reports.
A "Letter of Agreement" (LOA) between the grantee and grantor will be required once a grant has been approved, and prior to funding. Funding of Clinical Research grants are made in a minimum of two payments, with the first installment paid upon the grantor's receipt of two fully executed copies of the LOA.
Subsequent payments will be contingent upon semi-annual reports and the Foundation board's assessment that patient recruitment is taking place and reasonable progress made. In accordance with US Government policy, proof will be required that the organization is a legally designated not-for-profit organization and a legitimate research institution.
The Foundation's Board of Trustees has determined that funding will fall into the following categories: clinical research, physician and public awareness of the hazards of sleep-disordered breathing, and community philanthropic involvement. The primary focuses of Foundation Grants are "sleep and breathing," with limited funds available for community support.
Currently the Foundation plans to disburse a total of up to $1,350,000 annually. The Foundation will entertain proposals for multi-year studies, if warranted. However, for multi-year studies the Foundation will require an annual review at which time the board will ascertain whether the funded entity is keeping to its timeline and making progressive steps toward completion.
The board may reserve the right to discontinue further funding if a study is not moving forward as outlined in the proposal, nor reaching recruitment goals.
Clinical Research Proposals The ResMed Foundation's key mission is to promote novel research as well as public and clinician awareness of sleep disordered breathing (SDB) and other respiratory disorders, with a primary focus on positive airway pressure and ventilation-based treatments. The Foundation will consider proposals focused on the evaluation, diagnosis, treatment and management of SDB and other respiratory disorders.
Research areas of interest include the most common and/or impactful comorbidities that are associated with SDB, especially metabolic syndrome including insulin sensitivity, obesity and especially cardiovascular diseases. Other areas of focus include SDB in conjunction with occupational health and safety, asthma, chronic obstructive pulmonary disease (COPD), and solid tumors.
Specific focus is on outcomes that can influence clinical practice in the near term.
In 2022, the ResMed Foundation is particularly interested in: Research proposals that utilize advanced analytics and data science, especially the use of Machine Learning (ML) and Artificial Intelligence (AI), in the analysis of large sets of data from a variety of relevant sources (EHR, lab, claims, sensors/wearables, connected devices, remote physiologic and remote therapeutic monitoring, software/digital health platforms, etc.).
Research based on real-world data (RWD) that generates high-quality real-world evidence (RWE). Health Economics and Outcomes Research (HEOR). Pragmatic research and clinical trials that accelerate the integration of research, policy and practice.
The Foundation encourages the publication of results in appropriate peer reviewed scientific and medical publications. A few examples of programs that the Foundation has funded are highlighted under Grant Recipients. Donor recipients must be a qualified tax-exempt organization under section 501 (c) 3 of the US Internal Revenue Service or have the equivalent designation by the federal governing agency in another country.
Grants will be given to organizations that demonstrate that they have competent management who have a history of delivering results in an effective and cost efficient manner. Indirect costs: The Foundation's policy is to consider a maximum of 4% of indirect/overhead costs; however the board's preference is to fund direct (program) costs only. Grants will be awarded with a clear expectation of measurable results and outcomes.
Reports to the Foundation will be required minimally on a semi-annual basis. In some cases quarterly reports are required. At the conclusion of the study a final report is required detailing how the funds were spent and definitive outcomes.
The Foundation will be provided a copy of all abstracts and published reports. A "Letter of Agreement" (LOA) between the grantee and grantor will be required once a grant has been approved, and prior to funding. Funding of Clinical Research grants are made in a minimum of two payments, with the first installment paid upon the grantor's receipt of two fully executed copies of the LOA.
Subsequent payments will be contingent upon semi-annual reports and the Foundation board's assessment that patient recruitment is taking place and reasonable progress made. In accordance with US Government policy, proof will be required that the organization is a legally designated not-for-profit organization and a legitimate research institution. Meet our latest partner - Scoopeya Designed and Developed by
Based on current listing details, eligibility includes: Researchers and institutions conducting studies in sleep and breathing health. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.